These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 31776331)
1. Engineering dendritic cell vaccines to improve cancer immunotherapy. Perez CR; De Palma M Nat Commun; 2019 Nov; 10(1):5408. PubMed ID: 31776331 [TBL] [Abstract][Full Text] [Related]
2. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies. Galati D; Zanotta S Cytotherapy; 2018 Nov; 20(11):1309-1323. PubMed ID: 30360963 [TBL] [Abstract][Full Text] [Related]
3. Dendritic Cells and Cancer Immunity. Gardner A; Ruffell B Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569 [TBL] [Abstract][Full Text] [Related]
4. The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells. Ramachandran M; Dimberg A; Essand M Semin Cancer Biol; 2017 Aug; 45():23-35. PubMed ID: 28257957 [TBL] [Abstract][Full Text] [Related]
5. Dendritic cells in tumor immunology and immunotherapy. Turtle CJ; Hart DN Curr Drug Targets; 2004 Jan; 5(1):17-39. PubMed ID: 14738216 [TBL] [Abstract][Full Text] [Related]
6. The clinical application of cancer immunotherapy based on naturally circulating dendritic cells. Bol KF; Schreibelt G; Rabold K; Wculek SK; Schwarze JK; Dzionek A; Teijeira A; Kandalaft LE; Romero P; Coukos G; Neyns B; Sancho D; Melero I; de Vries IJM J Immunother Cancer; 2019 Apr; 7(1):109. PubMed ID: 30999964 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy. Schreurs MW; Eggert AA; Punt CJ; Figdor CG; Adema GJ Crit Rev Oncog; 2000; 11(1):1-17. PubMed ID: 10795625 [TBL] [Abstract][Full Text] [Related]
16. Dendritic cells and their role in cancer immunotherapy. Jalili A Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012 [TBL] [Abstract][Full Text] [Related]
17. The role of dendritic cells in cancer. Lee YS; Radford KJ Int Rev Cell Mol Biol; 2019; 348():123-178. PubMed ID: 31810552 [TBL] [Abstract][Full Text] [Related]
18. Directing dendritic cell immunotherapy towards successful cancer treatment. Sabado RL; Bhardwaj N Immunotherapy; 2010 Jan; 2(1):37-56. PubMed ID: 20473346 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cells from bench to bedside and back. Adema GJ Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337 [TBL] [Abstract][Full Text] [Related]
20. Engineering Dendritic-Cell-Based Vaccines and PD-1 Blockade in Self-Assembled Peptide Nanofibrous Hydrogel to Amplify Antitumor T-Cell Immunity. Yang P; Song H; Qin Y; Huang P; Zhang C; Kong D; Wang W Nano Lett; 2018 Jul; 18(7):4377-4385. PubMed ID: 29932335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]